middle.news
Elixinol Builds Personalised Wellness Platform with Vitable Acquisition
9:06am on Thursday 24th of September, 2026 AEST
•
Consumer Health and Wellness
Read Story
Elixinol Builds Personalised Wellness Platform with Vitable Acquisition
9:06am on Thursday 24th of September, 2026 AEST
Key Points
A$2.5 million all-scrip acquisition of Vitable
More than 7,850 active subscribers and 1.84 million health assessments
Combined revenue target of A$27 million and approximately A$3 million EBITDA by 2028
Up to A$1 million market-capitalisation-linked Platform Kicker
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Elixinol Wellness (ASX:EXL)
OPEN ARTICLE